𝛼SK or Search

ENTITY

Acadia Pharmaceuticals (ACAD US)

28

Analysis

Health Care • United States

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

more

Refresh

Exchange Announcement • 25 Sep 2026 05:11

Current Report (Form 8-K | Period ending 2026-09-24)

Exchange Announcement • 12 Sep 2026 05:15

Current Report (Form 8-K | Period ending 2026-09-11)

Exchange Announcement • 05 Aug 2026 04:16

Current Report (Form 8-K | Period ending 2026-08-04)

Exchange Announcement • 04 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 11 Jun 2026 04:05

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x